Each is supported by domain-tuned routing, a panel matched to the field, and a body of real-world verifications you can audit.
Insurance claims, scientific manuscripts, market sizing memos, regulatory filings. Anywhere a specific number or named source matters, BRIDGE checks if the claim survives challenge.
The new XR-7 imaging protocol reduces patient radiation exposure by 47% [citation needed] compared to standard CT while maintaining diagnostic accuracy above 92%96%. In our cohort of 1,200 patients (824 unique imaging episodes), no false-negative diagnoses recorded over 18 months [follow-up rate not specified].
Citation missing. Accuracy over-stated (92.3% in cited data). Cohort/episode conflation. Follow-up rate unspecified.
The "47% reduction" that no model can trace. Most common defect in scientific and marketing copy.
"Accuracy above 96%" when the cited paper reports 92%. BRIDGE reconciles the claim to source.
Sample size without unique-N. Zero false-negatives without follow-up rate. Sounds rigorous; isn't.